Kopran Limited
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides d… Read more
Market Cap & Net Worth: Kopran Limited (KOPRAN)
Kopran Limited (NSE:KOPRAN) has a market capitalization of $68.03 Million (₹5.89 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #22984 globally and #1192 in its home market, demonstrating a -0.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Kopran Limited's stock price ₹122.01 by its total outstanding shares 48285605 (48.29 Million).
Kopran Limited Market Cap History: 2015 to 2026
Kopran Limited's market capitalization history from 2015 to 2026. Data shows growth from $39.62 Million to $68.03 Million (8.03% CAGR).
Kopran Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Kopran Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Kopran Limited's market cap is 0.01 times its annual revenue
0.84x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.22x
Kopran Limited's market cap is 0.22 times its annual earnings
11.15x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $27.52 Million | $2.96 Billion | $107.19 Million | 0.01x | 0.26x |
| 2017 | $35.69 Million | $3.10 Billion | $199.12 Million | 0.01x | 0.18x |
| 2018 | $20.45 Million | $3.05 Billion | $204.86 Million | 0.01x | 0.10x |
| 2019 | $16.39 Million | $3.49 Billion | $240.23 Million | 0.00x | 0.07x |
| 2020 | $73.92 Million | $3.50 Billion | $210.20 Million | 0.02x | 0.35x |
| 2021 | $173.86 Million | $4.81 Billion | $616.06 Million | 0.04x | 0.28x |
| 2022 | $82.24 Million | $4.74 Billion | $610.31 Million | 0.02x | 0.13x |
| 2023 | $133.16 Million | $5.48 Billion | $272.33 Million | 0.02x | 0.49x |
| 2024 | $118.08 Million | $6.15 Billion | $509.56 Million | 0.02x | 0.23x |
| 2025 | $83.87 Million | $6.30 Billion | $385.52 Million | 0.01x | 0.22x |
Competitor Companies of KOPRAN by Market Capitalization
Companies near Kopran Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Kopran Limited by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Kopran Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Kopran Limited's market cap moved from $39.62 Million to $ 68.03 Million, with a yearly change of 8.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹68.03 Million | -18.89% |
| 2025 | ₹83.87 Million | -28.97% |
| 2024 | ₹118.08 Million | -11.33% |
| 2023 | ₹133.16 Million | +61.92% |
| 2022 | ₹82.24 Million | -52.70% |
| 2021 | ₹173.86 Million | +135.21% |
| 2020 | ₹73.92 Million | +350.85% |
| 2019 | ₹16.39 Million | -19.85% |
| 2018 | ₹20.45 Million | -42.69% |
| 2017 | ₹35.69 Million | +29.69% |
| 2016 | ₹27.52 Million | -30.54% |
| 2015 | ₹39.62 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Kopran Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $68.03 Million USD |
| MoneyControl | $68.03 Million USD |
| MarketWatch | $68.03 Million USD |
| marketcap.company | $68.03 Million USD |
| Reuters | $68.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.